ConforMIS releases its next-generation iTotal G2 knee replacement system, the only patient-specific total knee replacement device left on the market.
Orthopedics devices maker ConforMIS released the latest iteration of its iTotal G2 total knee replacement system, the only such device on the market today, according to the company.
The G2 represents a years' worth of surgeon feedback on the original design, which the FDA cleared in January 2011 and was released to a limited group of surgeons a few months later, according to a press release.
Rates of total knee replacement surgeries have doubled since 1991 and post-procedure complications are on the rise, leading some researchers to wonder whether physicians are playing fast and loose with knee patients.
A dramatic increase in surgical knee replacement has some researchers concerned that the procedure may be misused.
The ratio of Medicare patients undergoing total knee arthroplasty (TKA) jumped 99.2% between 1991 and 2010, from 31.2 procedures per 10,000 Medicare enrollees to 62.1 procedures per 10,000 enrollees, according to a new study.
"The growth in TKA should prompt consideration of whether too many (or too few) of these procedures are being performed both in aggregate and among key patient subgroups defined by race, sex, or age," the authors wrote.
A jury decides in Zimmer's favor that the Gel-One arthritis knee pain treatment doesn't infringe on Genzyme's patents.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
DJO Global hopes its new OA Nano knee brace, which weighs in at 14.2 ounces, can help patients with knee pain stave off total knee replacement surgeries for years.
DJO Global is hoping its OA Nano knee brace can help patients get a leg up on knee replacement surgery.
Calling it a "game-changer," DJO sales & marking director Brian Moore told MassDevice that at 14.2 ounces, the OA nano is the lightest knee brace of its kind in the world. And the Vista, Calif.-based medical device company is hoping more knee pain or osteoarthritis sufferers can use the brace to forgo total knee replacement surgery, possibly for years.
Patients who undergo total hip or knee replacement surgery may multiply their risk of heart attack 25-fold in the weeks following the procedure, researchers say.
Total knee and hip replacement surgeries may temporarily increase a patient's risk of myocardial infarction during the period immediately after the procedure, researchers said.
The effect was greatest during the 6 weeks following total hip replacement surgery among patients aged 80 and older, who faced a 25.3% increased risk of suffering acute myocardial infarction, according to the study.
The risk was more pronounced in female patients of all ages, for which researchers reported a 21.7% heart attack risk increase compared with 12.8% for male patients.
Histogenics raises $49 million to fund a Phase III trial of its NeoCart regenerative knee cartilage treatment and get CE Mark approval for its VeriCart knee treatment in the European Union.
Histogenics said it raised another $49 million for its regenerative cartilage treatments, as it proceeds with a clinical trial for its NeoCart treatment and pursues CE Mark approval for its VeriCart system.
The round was led by Sofinnova Ventures and including backing from new investors Split Rock Partners, BioMed Ventures and FinTech GIMV Fund. Prior backers ProChon Holdings BV, Altima Partners, Foundation Medical Partners, Inflection Point Capital and Boston Millennia Partners also kicked in.